Olympic Protein Sciences LLC

Olympic Protein Technologies (OPT) is a contract research organization focused on providing high-quality protein science services for clients and partners. OPT currently offers construct design, expression, protein production & characterization, biomolecular interaction analysis, and protein engineering services. Our goal is to facilitate the success of your project through excellent work and clear communication. The aim of our team is to leverage this knowledge to provide the best experience and outcomes for our partners and clients by providing quality science delivered with full engagement and the highest standards, integrity, and data security. We also can leverage our network of protein science contacts to provide access to other types of analyses, such as advanced biophysical technologies, for your project. As we grow we will build on our existing capabilities while broadening our offerings to include additional protein science services. Prior to founding Olympic Protein Technologies, Mike served as the Chief Scientific Officer at ContraFect Corporation leading the team to build their discovery and development pipeline including CF-301, CF-296, and CF-404 for the treatment of infectious diseases. High protein expression through DNA sequence optimization and cloning into specialized expression vectors.